• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Techcouver.com

 
 
 
  • News
  • Web3
  • Thought Leadership
  • Bulletin Board
  • Job Board
  • About
    • Contact Us
  • Advertise

Pfizer

Acuitas Partners On mRNA Vaccines And Therapeutics With Pfizer

January 10, 2022 by Techcouver Newsdesk Leave a Comment

Vancouver’s Acuitas Therapeutics and Pfizer have entered into a Development and Option agreement under which Pfizer will have the option to license, on a non-exclusive basis, Acuitas’ LNP technology for up to 10 targets for vaccine or therapeutic development. Acuitas is focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics. […]

Filed Under: News Tagged With: Acuitas, Pfizer

Primary Sidebar

 
 
 

Stay Connected

About Us

Techcouver provides real-time reporting and analysis of emerging technology news in Vancouver and throughout British Columbia. The … READ MORE... about About Us

Copyright © 2022 Incubate Ventures

Privacy Policy